Phase 1 Affect Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Acetazolamide for Treatment Resistant Schizophrenia
SchizophreniaSchizo Affective Disorder
Vishwajit Nimgaonkar, MD PhD60 enrolled2 locationsNCT04887792
Recruiting
Phase 1Phase 2
Ocrelizumab for Psychosis by Autoimmunity
SchizophreniaSchizo-Affective Type of Psychosis
The Methodist Hospital Research Institute40 enrolled1 locationNCT03971487
Recruiting
Phase 1Phase 2
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
Active Noninfectious Uveitis Affecting the Posterior Segment
Regeneron Pharmaceuticals72 enrolled4 locationsNCT07218770
Recruiting
Phase 1Phase 2
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
SchizophreniaSchizo Affective Disorder
Vishwajit Nimgaonkar, MD PhD160 enrolled1 locationNCT03794076
Recruiting
Phase 1Phase 2
Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.
Obesity, ChildhoodCesarean Delivery Affecting Newborn
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT03298334
Completed
Phase 1
A Randomized, Single-blind, Single-dose, 3-arm, Parallel Group Study to Determine the Pharmacokinetic Similarity of ABP 710 and Infliximab (Remicade 'Registered Trademark') in Healthy Adult Subjects
Infliximab is currently used to treat patients with adult and pediatric inflammatory conditions. These inflammatory conditions affects various body systems such as gastrointestinal (Crohn’s disease).
Amgen Inc, USA.150 enrolled2 locationsACTRN12614000903684